The Premature Termination of the Phase III SALAMANDER Trial of REX-001, an Autologous Bone Marrow Cell Therapy, for Chronic Limb Ischemia in Diabetic Patients: Insights and Outcomes.
Saved in:
| Title: | The Premature Termination of the Phase III SALAMANDER Trial of REX-001, an Autologous Bone Marrow Cell Therapy, for Chronic Limb Ischemia in Diabetic Patients: Insights and Outcomes. |
|---|---|
| Authors: | Peeters JAHM; Department of Vascular Surgery, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., Hamming JF; Department of Vascular Surgery, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., Quax PHA; Department of Vascular Surgery, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., Schepers A; Department of Vascular Surgery, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands. Electronic address: A.Schepers@lumc.nl. |
| Source: | Annals of vascular surgery [Ann Vasc Surg] 2026 May 12; Vol. 130, pp. 282-289. Date of Electronic Publication: 2026 May 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8703941 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1615-5947 (Electronic) Linking ISSN: 08905096 NLM ISO Abbreviation: Ann Vasc Surg Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1615-5947 |
|---|---|
| DOI: | 10.1016/j.avsg.2026.04.044 |
